Intrinsic activated microglia map to the peri-infarct zone in the subacute phase of ischemic stroke

Christopher J S Price1, Dechao Wang, David K Menon

  • 1Department of Medicine, University of Cambridge, Addenbrookes Hospital, Cambridge, UK. cp252@medschl.cam.ac.uk

Stroke
|June 10, 2006
PubMed
Abstract

Insights

Microglial activation in ischemic stroke patients is minimal before 72 hours. Beyond this, it increases in the core infarction, peri-infarct zone, and contralateral hemisphere for up to 30 days.

Area of Science:

  • Neuroscience
  • Immunology
  • Radiology

Background:

  • Microglial activation is a key component of neuroinflammation following ischemic stroke.
  • Previous in vivo studies in stroke patients utilized positron emission tomography with (R)-PK11195 to assess microglial activation.
  • Understanding the temporal and spatial patterns of microglial activation is crucial for stroke research.

Purpose of the Study:

  • To establish temporal and spatial patterns of microglial activation in ischemic stroke patients.
  • To specifically investigate microglial activation in the peri-infarct zone.
  • To utilize positron emission tomography with [11C](R)-PK11195 for in vivo imaging.

Main Methods:

  • Carotid territory ischemic stroke patients were studied in three time windows up to 30 days post-ictus.
  • Positron emission tomography with [11C](R)-PK11195 was used to measure binding potential, with cerebral blood volume (CBV) correction.
  • Data were coregistered to MRI, and analysis involved a reference tissue model using the ipsilateral cerebellum.

Main Results:

  • Significant binding potential increases were observed beyond 72 hours and extended to 30 days post-stroke.
  • Elevated binding potential was detected in the core infarction, peri-infarct zone, and contralateral hemisphere.
  • The ipsilateral cerebellum was validated as a suitable reference tissue for analysis.

Conclusions:

  • Microglial activation in ischemic stroke patients is minimal before 72 hours.
  • Activation persists and increases in multiple brain regions up to 30 days post-ictus.
  • This extended timeframe suggests potential therapeutic opportunities beyond traditional neuroprotection windows.

Related Concept Videos